GSE119369 H10 inhibition 3 v 5 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE119369_H10 inhibition_3_v_5_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE119369_H10 inhibition_3_v_5_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE119369_H10 inhibition_3_v_5_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE119369_H10 inhibition_3_v_5_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

cytoskeleton regulator RNA

Gene

CENPB DNA-binding domain containing 1, pseudogene

Gene

nudix hydrolase 16 like 2, pseudogene

Gene

ID2 antisense RNA 1

Gene

aspartic peptidase retroviral like 1

Gene

microRNA 3648-2

Gene

microRNA 3648-1

Gene

uncharacterized LOC101928994

Gene

tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon pseudogene 7

Gene

aldehyde oxidase 2, pseudogene

  • Gene

    cytoskeleton regulator RNA


  • Gene

    CENPB DNA-binding domain containing 1, pseudogene


  • Gene

    nudix hydrolase 16 like 2, pseudogene


  • Gene

    ID2 antisense RNA 1


  • Gene

    aspartic peptidase retroviral like 1




  • Gene

    uncharacterized LOC101928994


  • Gene

    tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon pseudogene 7


  • Gene

    aldehyde oxidase 2, pseudogene

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.